Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON43931Active, not recruiting
Open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and Disruptive behavior disorders (DBD), sponsored by Utrecht University. Primary endpoints: Trait empathy, State empathy and 2 more. Started Jun 2015; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON43931.